Memorial Sloan Kettering Cancer Center (only recruiting to the Vascular/Angiosarcoma cohort) — New York, New York

Memorial Sloan Kettering Cancer Center (only recruiting to the Vascular/Angiosarcoma cohort) is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Memorial Sloan Kettering Cancer Center (only recruiting to the Vascular/Angiosarcoma cohort) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: SARCOMA.

Sponsors: Memorial Sloan Kettering Cancer Center.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Memorial Sloan Kettering Cancer Center (only recruiting to the Vascular/Angiosarcoma cohort)?

Memorial Sloan Kettering Cancer Center (only recruiting to the Vascular/Angiosarcoma cohort) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Memorial Sloan Kettering Cancer Center (only recruiting to the Vascular/Angiosarcoma cohort) conducted?

Memorial Sloan Kettering Cancer Center (only recruiting to the Vascular/Angiosarcoma cohort) has 1 clinical trials on record, with 1 currently active. Their work covers SARCOMA.

Is Memorial Sloan Kettering Cancer Center (only recruiting to the Vascular/Angiosarcoma cohort) accredited by Crixeo Health?

Memorial Sloan Kettering Cancer Center (only recruiting to the Vascular/Angiosarcoma cohort) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Memorial Sloan Kettering Cancer Center (only recruiting to the Vascular/Angiosarcoma cohort)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.